Skip to content

A Multidisciplinary Intervention for Weight Loss

Efficacy and Safety of a Long-term Multidisciplinary Weight Loss Intervention in Patients With Obesity: an Open Label Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04622982
Enrollment
151
Registered
2020-11-10
Start date
2016-02-01
Completion date
2020-09-30
Last updated
2020-11-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Brief summary

This is an open label study in which obese participants were treated with a restrictive hypo-caloric diet under hospitalization for a maximum period of 3 months in a metabolic rehabilitation unit. A multidisciplinary approach was used (combination of diet, physical exercise and psychotherapy)

Interventions

OTHERMultidisciplinary treatment of obesity (diet + vitamin D + exercise + psychotherapy)

Body weight reduction was induced by a low-energy mixed diet (55 % carbohydrates, 30 % lipids and 15 % proteins) providing 600 kcal less than individually estimated energy requirements based on the measured REE. The energy content and macronutrient composition of the diets adhered to the nutritional recommendations of the American Diabetes Association. Patients were administered vitamin D supplement only if they presented a value of 25-hydroxyvitamin D (25OHD) \<30 ng/ml in blood tests at the beginning. Patients were following an individualized physical activity plan within the hospital and were aided by a psychodynamic approach therapist.

Sponsors

Azienda di Servizi alla Persona di Pavia
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Open Label study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age \>= 18 * BMI \>= 30 * one or more comorbidities (type 2 diabetes mellitus, dyslipidemia, high blood pressure, hyperuricemia, and others)

Exclusion criteria

* active cancer * severe cognitive or functional impairments * severe behavioral disorders * known kidney failure (previous glomerular filtration rate \<30 ml/min) * known liver failure (Child B or C)

Design outcomes

Primary

MeasureTime frameDescription
Body Weight12 weeksChange in body Weight

Secondary

MeasureTime frameDescription
Insulin12 weeksChange in insulin blood levels
Homa IR12 weeksChange in HOMA-IR
Total cholesterol12 weeksChange in blood total cholesterol
LDL cholesterol12 weeksChange in LDL cholesterol
HDL cholesterol12 weeksChange in HDL cholesterol
GlycaemIa12 weeksChange in glycaemia
AST (Aspartate Aminotransferase)12 weeksChange in blood of Aspartate Aminotransferase (AST)
ALT (alanine aminotransferase)12 weeksChange in blood of alanine aminotransferase (ALT)
GGT (gamma-glutamyl transpeptidase)12 weeksChange in blood of gamma-glutamyl transpeptidase (GGT)
Total bilirubin12 weeksChange in blood total bilirubin
Basal metabolic rate12 weeksChange in basal metabolic rate
Triglycerides12 weeksChange in triglycerides

Other

MeasureTime frameDescription
Other biochemical parameters - albumin12 weeksChange in blood proteins (albumin)
Other biochemical parameters - prealbumin12 weeksChange in blood proteins (prealbumin)
Other biochemical parameters - enzymes - lipase12 weeksChange in blood enzymes (lipase)
Other biochemical parameters - enzymes - amylase12 weeksChange in blood enzymes (amylase)
Other biochemical parameters - thyroid hormones - FT312 weeksChange in FT3
Body composition - Body Fat Mass12 weeksChange in Body Fat
Other biochemical parameters - thyroid hormones - TSH12 weeksChange in TSH
Other biochemical parameters - inflammatory markers - CRP12 weeksChange in C-reactive protein
Other biochemical parameters - inflammatory markers - ESR12 weeksChange in Erythrocyte Sedimentation Rate
Other biochemical parameters - creatinin12 weeksChange in blood creatinin
Uric acid12 weeksChange in uric acid blood concentration
Other biochemical parameters - thyroid hormones - FT412 weeksChange in FT4
Body composition - Body Fat free mass12 weekschange in Body Fat free mass
Body composition - Visceral Fat mass12 weekschange in Visceral Fat mass
Body Circumferences - arm12 weekschange in circumferences (arm)
Body Circumferences - calf12 weekschange in circumferences (calf)
Body Circumferences - waist12 weekschange in circumferences ( waist)
Body Circumferences - hips12 weekschange in circumferences (hips)
Iron12 weeksChange in blood Iron concentration
Other biochemical parameters - vit D12 weeksChange in blood vitamin D
Other biochemical parameters - vit B1212 weeksChange in blood vitamin B12
Other biochemical parameters - Folates12 weeksChange in blood Folates
Other biochemical parameters - transferrin12 weeksChange in transferrin
Other biochemical parameters - Homocystein12 weeksChange in Homocystein

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026